SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotime-Nasdaq's best kept secret?
BTIM 0.00010000.0%1:26 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: John L. who wrote (1332)7/27/1999 11:12:00 PM
From: mesaone   of 1432
 
did you attend the meeting? and did you introduce yourself to me. i have not been keeping up with SI.. my focus is elsewhere.. so i apologize for my delay in responding. yes, i did attend, and i spoke my mind about pr. i think that the cards are not on the table yet.. and i also think that abbott may play a more important role than we anticipated. i base this on the fact that ABT had dedicated 1/3 of their total sales force to selling Hextend. Furthermore, Hextend is not going to be "bundled" with the other products ABT sells.. and as a final vote of confidence, ABT is directing their sales force to the crystalloid and the albumen market.. and not even thinking about hespan. It would seem to me that ABT doesnt even care about hespan.. perhaps hespan will obsolete... you draw your own conclusions. i think revs will speak for themselves. I also think the short shills over at yahoo are working overtime.. trying to spin what ever they can... but , like the shorts said from day one.. and i repeate here.. let's see the revs.... i am content with my long position.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext